A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Trial of Four Doses of Tasosartan in Patients With Essential Hypertension

Verfasser / Beitragende:
[Yves Lacourcière, James L. Pool, Laura Svetkey, Alan H. Gradman, Pierre Larochelle, Jacques de Champlain, William B. Smith]
Ort, Verlag, Jahr:
1998
Enthalten in:
American Journal of Hypertension, 11/4(1998-04), 454-461
Format:
Artikel (online)
ID: 398282331